Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Tumoral prostate shows different expression pattern of somatostatin receptor 2 (SSTR2) and phosphotyrosine phosphatase SHP-1 (PTPN6) according to tumor progression
Advances in Urology, 07/09/09
Cariaga-Martinez AE et al. - Somatostatin receptor 2 (SSTR2) and SHP-1 tyrosine phosphatase are 2 fundamental components on antiproliferative effect of somatostatin. Normal epithelial prostate cells express SHP-1 and SSTR2, but their expression levels are diminished or lost in advanced prostate cancer with an inverse ratio between protein expression and Gleason grade of tumor.
Methods- An evaluation of the expression of SSTR2 and SHP-1 (PTPN6) in normal prostate and their variation through tumoral progression in human prostate cancer
- Human prostate tissues were obtained from transrectal needle biopsies, transurethral resection, and retropubic or radical prostatectomy
- Specimens were graded according to the original report Gleason grading
- IHC was performed with different antibodies
- Epithelial expressions of both proteins, SHP-1 and SSTR2, in normal and benign hyperplasia are localized in the luminal side of duct and acinar cells
- Also, SSTR2 was expressed in stromal cells
- In malignant prostate tissue, SHP-1 was diminished in 28/45 cases or absent in 12/45 cases
- SSTR2 epithelial was diminished in 38/45 cases or lost in only 2/45 cases
- The intensity of immunostained was highly negative correlated with Gleason grade for 2 proteins
Related Articles
Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4 + 3 and Gleason 3 + 4 Tumors in a Population Based Cohort
The Journal of Urology, 11/20/09
Relevance Score: 69%
Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study
Journal of Clinical Oncology, 11/03/09
Relevance Score: 69%
Progressive epithelial to mesenchymal transitions in ARCaPE prostate cancer cells during xenograft tumor formation and metastasis
The Prostate, 11/19/09
Relevance Score: 68%
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
Cancer Immunology, Immunotherapy, 10/26/09
Relevance Score: 68%
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/16/09
Relevance Score: 68%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutation analysis of the MSMB gene in familial prostate cancer
British Journal of Cancer, 12/10/09
Small Variations in Crucial Steps of Tunel Assay Coupled to Flow Cytometry Greatly Affect Measures of Sperm DNA Fragmentation
Journal of Andrology, 12/09/09
Estrogen Receptor alpha and beta Polymorphisms Are Associated with Semen Quality
Journal of Andrology, 12/08/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutation analysis of the MSMB gene in familial prostate cancer
British Journal of Cancer, 12/10/09
[F18]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study
European Journal of Cancer, 12/10/09
Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
Cancer, 12/10/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutation analysis of the MSMB gene in familial prostate cancer
British Journal of Cancer, 12/10/09
[F18]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study
European Journal of Cancer, 12/10/09
Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
Cancer, 12/10/09
Article Search
Sponsor


See Latest Articles


